CD31+/Annexin V+ microparticles in healthy offsprings of patients with coronary artery disease.
about
Noncoding RNAs regulate NF-κB signaling to modulate blood vessel inflammationRole of Platelet-Derived Microvesicles As Crosstalk Mediators in Atherothrombosis and Future Pharmacology Targets: A Link between Inflammation, Atherosclerosis, and ThrombosisEffects of immunoadsorption on endothelial function, circulating endothelial progenitor cells and circulating microparticles in patients with inflammatory dilated cardiomyopathy.Acetylsalicylate reduces endothelial and platelet-derived microparticles in patients with coronary artery disease.Endurance capacity is not correlated with endothelial function in male university students.Circulating endothelial microparticles as a measure of early lung destruction in cigarette smokers.Critical reevaluation of endothelial progenitor cell phenotypes for therapeutic and diagnostic use.Levels of circulating endothelial cells and colony-forming units are influenced by age and dyslipidemia.Cell-derived microparticles in atherosclerosis: biomarkers and targets for pharmacological modulation?Microparticles and microRNAs: new players in the complex field of coagulation.Endothelial microparticles: missing link in endothelial dysfunction?Microparticles, not only markers but also a therapeutic target in the early stage of diabetic retinopathy and vascular aging.Endothelial dysfunction: its clinical value and methods of assessment.Circulating cell-derived microparticles as biomarkers in cardiovascular disease.Evaluation of microparticles in whole blood by multicolour flow cytometry assay.Correlation between brachial artery flow-mediated dilation and endothelial microparticle levels for identifying endothelial dysfunction in children with Kawasaki disease.
P2860
Q26865593-65AF1A45-E6CC-4FE8-9162-2CE49135251AQ28069254-7AA657D0-5157-43DC-99A7-C40779A86D34Q33813731-E5B45B0D-1560-4735-A970-54AFCB8365D4Q33888658-B42BB12A-FC5D-4F61-B17A-DA25B903E0FAQ34015476-15A12490-F1B7-4F60-B929-229B25C9E9A6Q35212590-3B4FD394-44E8-49BB-A98F-457968D2B5B8Q36055443-6449E2B3-0027-4CE2-A17F-9D50519D87DEQ36705957-A9EF0D2F-8D12-4560-8E59-894E52D3803FQ37295504-EF231A45-C7A7-472F-92DF-1CF7FA86AB65Q37950250-4D64013E-959C-4093-969F-9615591BA259Q38001993-ED513CEB-EA11-420E-93A6-CC1E8C5D9F63Q38012180-4E32CA55-11A7-47E5-9D7F-B5089AEF6001Q38206989-65037F5E-9322-4617-BB70-EFFA386C2325Q38944216-044D74E1-CA3A-4F2D-8BF3-7613A5FED929Q44284893-E74A6D12-EEF8-4430-AEEF-B19955EA7767Q54442928-4FDB594E-0936-450B-A942-8079781481AD
P2860
CD31+/Annexin V+ microparticles in healthy offsprings of patients with coronary artery disease.
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
CD31+/Annexin V+ microparticle ...... with coronary artery disease.
@ast
CD31+/Annexin V+ microparticle ...... with coronary artery disease.
@en
type
label
CD31+/Annexin V+ microparticle ...... with coronary artery disease.
@ast
CD31+/Annexin V+ microparticle ...... with coronary artery disease.
@en
prefLabel
CD31+/Annexin V+ microparticle ...... with coronary artery disease.
@ast
CD31+/Annexin V+ microparticle ...... with coronary artery disease.
@en
P2093
P2860
P1476
CD31+/Annexin V+ microparticle ...... with coronary artery disease.
@en
P2093
P2860
P356
10.1111/J.1365-2362.2008.02058.X
P577
2009-01-01T00:00:00Z